LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
ELI LILLY & Co
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$1240.34−16.69 (-1.33%)
Close on Oct 19, 2026
- Market cap
- $1.11T
- P/E (TTM)
- 41.6
- Dividend yield
- 0.50%
Eli Lilly statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Eli Lilly | Industry median |
|---|---|---|
| Market Cap | $1.17T | $197.05M |
| Enterprise Value | $1.21T | $106.56M |
| PE Ratio | 41.62 | 20.52 |
| PS Ratio | 14.66 | 3.93 |
| PB Ratio | 34.46 | 2.14 |
| P/TBV Ratio | 168.73 | 2.46 |
| P/OCF Ratio | 41.58 | 13.78 |
Enterprise value
| Measure | Eli Lilly | Industry median |
|---|---|---|
| EV / Sales | 15.23 | 2.69 |
| EV / EBITDA | 34.00 | 14.86 |
Income (trailing twelve months)
| Measure | Eli Lilly | Industry median |
|---|---|---|
| Revenue | $79.67B | $57.94M |
| Gross Profit | $66.44B | $90.47M |
| Pretax Income | $33.60B | -$14.45M |
| Net Income | $26.71B | -$22.46M |
| EBITDA | $35.69B | -$16.91M |
| EPS (Diluted) | $29.80 | -$0.83 |
Margins
| Measure | Eli Lilly | Industry median |
|---|---|---|
| Gross Margin | 83.4% | 52.3% |
| Pretax Margin | 42.2% | -13.0% |
| Profit Margin | 33.5% | -39.2% |
| EBITDA Margin | 44.8% | -31.3% |
Returns
| Measure | Eli Lilly | Industry median |
|---|---|---|
| Return on Equity (ROE) | 102.4% | -53.1% |
| Return on Assets (ROA) | 22.0% | -41.0% |
Growth
| Measure | Eli Lilly | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 49.6% | 6.01% |
| Net Income Growth (YoY) | 93.6% | -37.7% |
| EPS Growth (YoY) | 94.8% | -29.2% |
| Revenue Growth (3Y CAGR) | 31.7% | 2.25% |
| Revenue Growth (5Y CAGR) | 21.6% | 6.42% |
| EPS Growth (3Y CAGR) | 49.3% | -0.17% |
| EPS Growth (5Y CAGR) | 27.6% | 3.77% |
Balance sheet
| Measure | Eli Lilly | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $8.95B | $62.42M |
| Total Debt | $54.91B | $120.13M |
| Net Cash (Debt) | -$45.96B | $15.68M |
| Net Cash Per Share | -$48.82 | $0.65 |
| Equity (Book Value) | $33.88B | $48.79M |
| Book Value Per Share | $35.99 | $1.36 |
| Tangible Book Value | $6.92B | $23.06M |
| Working Capital | $16.93B | $75.77M |
Financial position
| Measure | Eli Lilly | Industry median |
|---|---|---|
| Current Ratio | 1.35 | 3.30 |
| Quick Ratio | 0.61 | 2.39 |
| Debt / Equity | 1.62 | 0.51 |
| Debt / EBITDA | 1.54 | 3.35 |
| Net Debt / EBITDA | 1.29 | 2.22 |
Cash flow (trailing twelve months)
| Measure | Eli Lilly | Industry median |
|---|---|---|
| Operating Cash Flow | $28.08B | -$12.35M |
Efficiency
| Measure | Eli Lilly | Industry median |
|---|---|---|
| Asset Turnover | 0.66 | 0.38 |
| Inventory Turnover | 0.95 | 2.67 |
| Revenue Per Employee | $1.59M | $398.96K |
| Profits Per Employee | $534.22K | -$732.08K |
| Employee Count | 50,000 | 73 |
Dividends and yields
| Measure | Eli Lilly | Industry median |
|---|---|---|
| Earnings Yield | 2.29% | -21.2% |
| Dividend Yield | 0.50% | 1.83% |
| Buyback Yield | 0.53% | -0.58% |
| Shareholder Yield | 1.03% | 0.00% |
| Dividend Per Share | $6.23 | $0.83 |
| Dividend Growth (YoY) | 15.4% | 2.37% |
| Years of Dividend Growth | 9 | 0 |
| Payout Ratio | 21.7% | 47.7% |
Shares
| Measure | Eli Lilly | Industry median |
|---|---|---|
| Shares Outstanding | 941,357,000 | 59,128,900 |
| Shares Change (YoY) | -0.61% | 11.1% |
| Float | 843,803,000 | 48,744,500 |
| Shares Held by Insiders | 10.4% | 11.8% |
| Shares Held by Institutions | 83.7% | 59.4% |
Taxes
| Measure | Eli Lilly | Industry median |
|---|---|---|
| Income Tax | $6.88B | $91.50K |
| Effective Tax Rate | 20.5% | 20.6% |
Scores
| Measure | Eli Lilly | Industry median |
|---|---|---|
| Graham Number | $155.34 | $17.36 |
| Graham Upside | -87.5% | -45.5% |
| Altman Z-Score | 7.48 | 0.10 |
| Piotroski F-Score | 7 | 4 |
| Beneish M-Score | -1.85 | -2.62 |
Calculated by StockData from Eli Lilly's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.